Beijing Tide Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 1995-05-29
- Employees
- -
- Market Cap
- -
- Website
- https://www.tidepharm.com
Beijing Tide's First-in-Class AT2R Antagonist TRD205 Enters Phase II Trials for Chronic Post-Surgical Pain
Beijing Tide Pharmaceutical has dosed the first patient in Phase II trials of TRD205, a first-in-class AT2R antagonist targeting chronic post-surgical neuropathic pain without opioid-related risks.
© Copyright 2025. All Rights Reserved by MedPath